Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)

Eitemau Tebyg

• Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
  gan: Stiletto, RJ, et al.
  Cyhoeddwyd: (1998)
• Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
  gan: Brunkhorst, FM, et al.
  Cyhoeddwyd: (1999)
• Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology
  gan: Willibald Wonisch, et al.
  Cyhoeddwyd: (2024-12-01)
• Procalcitonin (PCT)
  gan: Horns, Heidi, et al.
  Cyhoeddwyd: (2021)
• Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis
  gan: LIU, Yu, et al.
  Cyhoeddwyd: (2017)